Common BP Drug May Prevent Resistance to Tarceva in NSCLC Patients
News
A blood pressure-lowering drug called Edecrin (ethacrynic acid) may be used to prevent resistance to the lung cancer agent Tarceva (erlotinib), scientists from Imperial College London and Fudan University ... Read more